Meet the 7.3% Yield Dividend Stock That Could Soar in 2026
It's been a tough stretch for pharmaceutical giant (NYSE: PFE). The company enjoyed a vaccine windfall during the COVID-19 pandemic, but revenue and profits cratered as the pandemic eased and those tailwinds stopped blowing. The stock has tumbled, sending Pfizer's dividend yield to a whopping 7.3%.
But Pfizer's stock price recently bounced on its second-quarter earnings. Investors have been looking for a glimpse into Pfizer's future, and there is a lot to like as things begin to come into view.
Here is why Pfizer's newfound momentum could set the stock up to soar in 2026.
Source Fool.com
Pfizer Inc. Stock
We see a rather positive sentiment for Pfizer Inc. with 15 Buy predictions and 2 Sell predictions.
As a result the target price of 27 € shows a positive potential of 22.59% compared to the current price of 22.03 € for Pfizer Inc..


